Y
Yang Yang
Researcher at University of Electronic Science and Technology of China
Publications - 563
Citations - 19966
Yang Yang is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: Computer science & Medicine. The author has an hindex of 51, co-authored 419 publications receiving 13362 citations. Previous affiliations of Yang Yang include Nanyang Technological University & National University of Singapore.
Papers
More filters
Journal ArticleDOI
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Chenguang Shen,Zhaoqin Wang,Fang Zhao,Yang Yang,Jinxiu Li,Jing Yuan,Fuxiang Wang,Delin Li,Delin Li,Minghui Yang,Li Xing,Jinli Wei,Haixia Xiao,Haixia Xiao,Yan Yang,Jiuxin Qu,Ling Qing,Li Chen,Zhixiang Xu,Ling Peng,Yanjie Li,Haixia Zheng,Feng Chen,Kun Huang,Yujing Jiang,Dongjing Liu,Zheng Zhang,Yingxia Liu,Lei Liu +28 more
TL;DR: In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status, and these observations require evaluation in clinical trials.
Journal ArticleDOI
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
Yingxia Liu,Yang Yang,Cong Zhang,Cong Zhang,Fengming Huang,Fuxiang Wang,Jing Yuan,Zhaoqin Wang,Jinxiu Li,Jianming Li,Cheng Feng,Zheng Zhang,Lifei Wang,Ling Peng,Li Chen,Yuhao Qin,Dandan Zhao,Shuguang Tan,Lu Yin,Jun Xu,Cong-Zhao Zhou,Chengyu Jiang,Lei Liu +22 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China, suggest a number of potential diagnosis biomarkers and angiotensin receptor blocker drugs for potential repurposing treatment of 2019- nCoV infection.
Journal ArticleDOI
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
Qingxian Cai,Minghui Yang,Dongjing Liu,Jun Chen,Dan Shu,Junxia Xia,Xuejiao Liao,Yuanbo Gu,Qiu’e Cai,Yang Yang,Chenguang Shen,Xiaohe Li,Ling Peng,Deliang Huang,Jing Zhang,Shurong Zhang,Fuxiang Wang,Jiaye Liu,Li Chen,Shuyan Chen,Zhaoqin Wang,Zheng Zhang,Ruiyuan Cao,Wu Zhong,Yingxia Liu,Lei Liu +25 more
TL;DR: In this open-label nonrandomized control study, FPV showed significantly better treatment effects on COVID-19 in terms of disease progression and viral clearance; if causal, these results should be important information for establishing standard treatment guidelines to combat the SARS-CoV-2 infection.
Proceedings ArticleDOI
Adversarial Cross-Modal Retrieval
TL;DR: Comprehensive experimental results show that the proposed ACMR method is superior in learning effective subspace representation and that it significantly outperforms the state-of-the-art cross-modal retrieval methods.
Posted ContentDOI
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections
Yang Yang,Minghui Yang,Chenguang Shen,Fuxiang Wang,Jing Yuan,Jinxiu Li,Mingxia Zhang,Zhaoqin Wang,Li Xing,Jinli Wei,Ling Peng,Gary Wong,Haixia Zheng,Weibo Wu,Mingfeng Liao,Kai Feng,Jianming Li,Qianting Yang,Juanjuan Zhao,Zheng Zhang,Lei Liu,Yingxia Liu +21 more
TL;DR: Sputum is most accurate for laboratory diagnosis of NCP, followed by nasal swabs, followedby nasal swab, and detection of viral RNAs in BLAF is necessary for diagnosis and monitoring of viruses in severe cases.